(Q34713416)

4 August 2017

title

Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivo (English)

1 reference

4 August 2017

1 reference

A E Stephen

1

1 reference

4 August 2017

P T Masiakos

2

1 reference

4 August 2017

D L Segev

3

1 reference

4 August 2017

J P Vacanti

4

1 reference

4 August 2017

P K Donahoe

5

1 reference

4 August 2017

D T MacLaughlin

6

1 reference

4 August 2017

language of work or name

English

0 references

publication date

27 February 2001

1 reference

Proceedings of the National Academy of Sciences of the United States of America

4 August 2017

published in

1 reference

4 August 2017

volume

98

1 reference

4 August 2017

issue

6

1 reference

4 August 2017

page(s)

3214-3219

1 reference

Mullerian inhibiting substance inhibits ovarian cell growth through an Rb-independent mechanism

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

Controlling TGF-beta signaling

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

7 July 2018

Cancer statistics, 1999.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

Cleavage of Müllerian inhibiting substance activates antiproliferative effects in vivo.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

Pathology of ovarian cancer precursors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

Developmental expression of a candidate müllerian inhibiting substance type II receptor

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

Cell transplantation of genetically altered cells on biodegradable polymer scaffolds in syngeneic rats

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the müllerian duct

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

Purification of testicular anti-Müllerian hormone allowing direct visualization of the pure glycoprotein and determination of yield and purification factor.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

Source of the anti-Müllerian hormone synthesized by the fetal testis: Müllerian-inhibiting activity of fetal bovine Sertoli cells in tissue culture.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

Recent progress in ovarian cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

Beyond transplantation. Third annual Samuel Jason Mixter lecture.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

Novel regulators of bone formation: molecular clones and activities

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

Selective cell transplantation using bioabsorbable artificial polymers as matrices

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

Human recombinant mullerian inhibiting substance inhibition of rat oocyte meiosis is reversed by epidermal growth factor in vitro

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-beta

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

An immunoassay to detect human müllerian inhibiting substance in males and females during normal development

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

Müllerian Inhibiting Substance as a Marker for Ovarian Sex-Cord Tumor

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

The inhibitory effects of müllerian-inhibiting substance on epidermal growth factor induced proliferation and progesterone production of human granulosa-luteal cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

Human müllerian inhibiting substance: enhanced purification imparts biochemical stability and restores antiproliferative effects

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

Müllerian Duct Regression in the Embryo Correlated with Cytotoxic Activity Against Human Ovarian Cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

Growth of Human Tumor Xenografts Implanted under the Renal Capsule of Normal Immunocompetent Mice

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

Mullerian inhibiting substance fractionation by dye affinity chromatography.

7 July 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.051625998

Mullerian inhibiting substance inhibits colony growth of a human ovarian carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.051625998

Biological therapy of ovarian cancer: current directions

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30633

Abnormal sexual development in transgenic mice chronically expressing Müllerian inhibiting substance

26 October 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.051625998

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.051625998

Mullerian inhibiting substance reduction of colony growth of human gynecologic cancers in a stem cell assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.051625998

Subrenal capsule assay to test the viability of parenterally delivered müllerian inhibiting substance

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.051625998

A graded organ culture assay for the detection of Mullerian inhibiting substance

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.051625998

Tissue-isolated human tumor xenografts in athymic nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.051625998

Mullerian inhibiting substance inhibits growth of a human ovarian cancer in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.051625998

Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS

21 January 2018

1 reference

12 December 2020

Rapid growth of human cancer cells in a mouse model with fibrin clot subrenal capsule assay

1 reference

12 December 2020

Human müllerian inhibiting substance inhibits tumor growth in vitro and in vivo

1 reference

12 December 2020

Transplantation of genetically altered hepatocytes using cell-polymer constructs

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.051625998

1 reference

4 August 2017

0 references

1 reference

4 August 2017

1 reference